Follow this link to a listing of SEER SINQ's that have been finalized during the months of May thru July 2021.
Highlights of this listing include:
20210037 informs whether Thyroid Imaging Reporting and Data System (TI-RADS) 4a, 4b, or 5 on imaging is diagnostic of thyroid cancer and if so, can it be used for date of diagnosis?
20210038 advises how to correctly code 2021 neoadjuvant therapy fields when neoadjuvant therapy and surgery were part of first course of treatment plans but was never completed.
20210044 instructs if Serum Protein Electrophoresis (SPEP) can be used as a definitive diagnostic method in the absence of a bone marrow biopsy for Plasma Cell Myeloma cases.
If you have questions or concerns regarding any of the content of this CRGC News Broadcast please contact me.
